Works matching AU Vellenga, Edo

Results: 99

The multifaceted role of autophagy in cancer and the microenvironment.

Published in:

Medicinal Research Reviews, 2019, v. 39, n. 2, p. 517, doi. 10.1002/med.21531

By:

Folkerts, Hendrik;
Hilgendorf, Susan;
Vellenga, Edo;
Bremer, Edwin;
Wiersma, Valerie R.

Publication type:

Article

Elevated VMP1 expression in acute myeloid leukemia amplifies autophagy and is protective against venetoclax-induced apoptosis.

Published in:

Cell Death & Disease, 2019, v. 10, n. 6, p. N.PAG, doi. 10.1038/s41419-019-1648-4

By:

Folkerts, Hendrik;
Wierenga, Albertus T.;
van den Heuvel, Fiona A.;
Woldhuis, Roy R.;
Kluit, Darlyne S.;
Jaques, Jennifer;
Schuringa, Jan Jacob;
Vellenga, Edo

Publication type:

Article

Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.

Published in:

PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193098

By:

de Jong, Mathilde R. W.;
Visser, Lydia;
Huls, Gerwin;
Diepstra, Arjan;
van Vugt, Marcel;
Ammatuna, Emanuele;
van Rijn, Rozemarijn S.;
Vellenga, Edo;
van den Berg, Anke;
Fehrmann, Rudolf S. N.;
van Meerten, Tom

Publication type:

Article

Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'.

Published in:

Nature Genetics, 2005, v. 37, n. 3, p. 225, doi. 10.1038/ng1497

By:

Bystrykh, Leonid;
Weersing, Ellen;
Dontje, Bert;
Sutton, Sue;
Pletcher, Mathew T;
Wiltshire, Tim;
Su, Andrew I;
Vellenga, Edo;
Wang, Jintao;
Manly, Kenneth F;
Lu, Lu;
Chesler, Elissa J;
Alberts, Rudi;
Jansen, Ritsert C;
Williams, Robert W;
Cooke, Michael P;
de Haan, Gerald

Publication type:

Article

Bone marrow dysfunction in chronic heart failure patients.

Published in:

European Journal of Heart Failure, 2010, v. 12, n. 7, p. 676, doi. 10.1093/eurjhf/hfq061

By:

Westenbrink, B. Daan;
Voors, Adriaan A.;
de Boer, Rudolf A.;
Schuringa, Jan J.;
Klinkenberg, Theo;
van der Harst, Pim;
Vellenga, Edo;
van Veldhuisen, Dirk J.;
van Gilst, Wiek H.

Publication type:

Article

Breast Cancer Resistance Protein (BCRP) in Acute Leukaemia.

Published in:

Leukemia & Lymphoma, 2004, v. 45, n. 4, p. 649, doi. 10.1080/10428190310001597928

By:

Plasschaert, Sabine L.A.;
Van Der Kolk, Dorina M.;
De Bont, Eveline S.J.M.;
Vellenga, Edo;
Kamps, Willem A.;
De Vries, Elisabeth G.E.

Publication type:

Article

cAMP/PKA-mediated Regulation of Erythropoiesis.

Published in:

Leukemia & Lymphoma, 2003, v. 44, n. 11, p. 1893, doi. 10.1080/1042819031000116715

By:

Boer, Arjen-Kars;
Drayer, A. Lyndsay;
Vellenga, Edo

Publication type:

Article

High Functional P-blycoprotein Activity is More Often Present in T-cell Acute Lymphoblastic Leukaemic Cells in Adults than in Children.

Published in:

Leukemia & Lymphoma, 2003, v. 44, n. 1, p. 85, doi. 10.1080/1042819021000040288

By:

Plasschaert, Sabine L.A.;
Vellenga, Edo;
de Bont, Eveline S.J.M.;
van der Kolk, Dorina M.;
Veerman, Anjo J.P.;
Sluiter, Wim J.;
Daenen, Simon M.G.;
de Vries, Elisabeth G.E.;
Kamps, Willem A.

Publication type:

Article

The Role of Drug Efflux Pumps in Acute Myeloid Leukemia.

Published in:

Leukemia & Lymphoma, 2002, v. 43, n. 4, p. 685, doi. 10.1080/10428190290016773

By:

Van der Kolk, Dorina M.;
de Vries, Elisabeth G.E.;
Müller, Michael;
Vellenga, Edo

Publication type:

Article

Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2.

Published in:

PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0128585

By:

Capala, Marta E.;
Maat, Henny;
Bonardi, Francesco;
van den Boom, Vincent;
Kuipers, Jeroen;
Vellenga, Edo;
Giepmans, Ben N. G.;
Schuringa, Jan Jacob

Publication type:

Article

ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML.

Published in:

PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0111568

By:

Capala, Marta E.;
Vellenga, Edo;
Schuringa, Jan Jacob

Publication type:

Article

Convergence of Hypoxia and TGFβ Pathways on Cell Cycle Regulation in Human Hematopoietic Stem/Progenitor Cells.

Published in:

PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093494

By:

Wierenga, Albertus T. J.;
Vellenga, Edo;
Schuringa, Jan Jacob

Publication type:

Article

Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells.

Published in:

Immunology, 2002, v. 107, n. 3, p. 316, doi. 10.1046/j.1365-2567.2002.01501.x

By:

Heijink, Irene H.;
Vellenga, Edo;
Borger, Peter;
Postma, Dirkje S.;
De Monchy, Jan G. R.;
Kauffman, Henk F.

Publication type:

Article

Interaction between nitric oxide and subsets of human T lymphocytes with differences in glutathione metabolism.

Published in:

Immunology, 2002, v. 107, n. 3, p. 334, doi. 10.1046/j.1365-2567.2002.01502.x

By:

Roozendaal, Ramon;
Kauffman, HENK F.;
Dijkhuis, Anne-Jan;
Ommen, Elisabeth T. V.;
Postma, Dirkje S.;
De Monchy, Jan G. R.;
Vellenga, Edo

Publication type:

Article

High Acute Myeloid Leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow.

Published in:

Cellular Oncology (2211-3428), 2011, v. 34, n. 4, p. 289, doi. 10.1007/s13402-011-0017-9

By:

Weidenaar, Alida;
Elst, Arja;
Koopmans-Klein, Gineke;
Rosati, Stefano;
Dunnen, Wilfred;
Meeuwsen-de Boer, Tiny;
Kamps, Willem;
Vellenga, Edo;
Bont, Eveline

Publication type:

Article

Eight versus four induction cycles of Carfilzomib, Thalidomide and Low-dose Dexamethasone: the Carthadex trial.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e220, doi. 10.1016/j.clml.2019.09.367

By:

Wester, Ruth;
Zweegman, Sonja;
Van der Holt, Bronno;
Jose, Kersten Marie;
Vellenga, Edo;
van Marwijk-Kooy, Marinus;
Asselbergs, Emelie;
de Weerdt, Okke;
Minnema, Monique;
Lonergan, Sarah;
Palumbo, Antonio;
Broijl, Annemiek;
Sonneveld, Pieter

Publication type:

Article

Comparative Value of Post-Remission Treatment in Cytogenetically Normal AML Subclassified by NPM1 and FLT3-ITD Allelic Ratio.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S27, doi. 10.1016/j.clml.2016.07.039

By:

Versluis, Jurjen;
Hout, Florentien in 't;
Devillier, Raynier;
van Putten, Wim;
Manz, Markus;
Vekemans, Marie-Christiane;
Legdeur, Marie-Cecile;
Passweg, Jakob;
Maertens, Johan;
Kuball, Jurgen;
Biemond, Bart;
Valk, Peter;
van der Reijden, Bert;
Meloni, Giovanna;
Schouten, Harry;
Vellenga, Edo;
Pabst, Thomas;
Willemze, Roel;
Lowenberg, Bob;
Ossenkoppele, Gert

Publication type:

Article

Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 2, p. 138, doi. 10.3816/CLML.2010.n.020

By:

Kneppers, Evelien;
Lokhorst, Henk M.;
Eeltink, Corien M.;
Huls, Gerwin;
Kersten, Marie José;
Koedam, Jan;
Minnema, Monique C.;
van Oers, Marinus H. J.;
Raymakers, Reinier A. P.;
Schaafsma, Martijn R.;
Vellenga, Edo;
Wijermans, Pierre W.;
Wittebol, Shulamiet;
Sonneveld, Pieter;
Zweegman, Sonja

Publication type:

Article

Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/camp system compared to freshly isolated T cells.

Published in:

British Journal of Pharmacology, 2003, v. 138, n. 8, p. 1441, doi. 10.1038/sj.bjp.0705193

By:

Heijink, Irene H.;
Vellenga, Edo;
Borger, Peter;
Postma, Dirkje S.;
de Monchy, Jan G.R.;
Kauffman, Henk F.

Publication type:

Article

The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.

Published in:

2000

By:

Birkenkamp, Kim U;
Tuyt, Leonore M L;
Lummen, Chantal;
Wierenga, Albertus T J;
Kruijer, Wiebe;
Vellenga, Edo;
Birkenkamp, K U;
Tuyt, L M;
Lummen, C;
Wierenga, A T;
Kruijer, W;
Vellenga, E

Publication type:

journal article

Interleukin-6 production by activated human monocytic cells is enhanced by MK-571, a specific inhibitor of the multi-drug resistance protein-1.

Published in:

1999

By:

Vellenga, Edo;
Tuyt, Leonore;
Wierenga, Bart-Jan;
Müller, Michael;
Dokter, Wim;
Vellenga, E;
Tuyt, L;
Wierenga, B J;
Müller, M;
Dokter, W

Publication type:

journal article

BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.

Published in:

PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189102

By:

Carretta, Marco;
Brouwers-Vos, Annet Z.;
Bosman, Matthieu;
Horton, Sarah J.;
Martens, Joost H. A.;
Vellenga, Edo;
Schuringa, Jan Jacob

Publication type:

Article

Interleukin-4 prevents the induction of G-CSF mRNA in human adherent monocytes in response to endotoxin and IL-1 stimulation.

Published in:

British Journal of Haematology, 1991, v. 79, n. 1, p. 22, doi. 10.1111/j.1365-2141.1991.tb08001.x

By:

Vellenga, Edo;
Dokter, Wim;
Wolf, Joost Th. M.;
Vinne, Bernard;
Esselink, Mariet T.;
Halie, M. Ruud

Publication type:

Article

Simultaneous expression and regulation of G-CSF and IL-6 mRNA in adherent human monocytes and fibroblasts.

Published in:

British Journal of Haematology, 1991, v. 78, n. 1, p. 14, doi. 10.1111/j.1365-2141.1991.tb04375.x

By:

Vellenga, Edo;
Van Der Vinne, Bernard;
De Wolf, Joost Th. M.;
Halie, M. Ruud

Publication type:

Article

Interleukin-4 suppresses the interleukin-3 dependent erythroid colony formation from normal human bone marrow cells.

Published in:

British Journal of Haematology, 1990, v. 74, n. 3, p. 246, doi. 10.1111/j.1365-2141.1990.tb02578.x

By:

De Wolf, Joost Th. M.;
Beentjes, John A. M.;
Esselink, Mariet T.;
Smit, Jan W.;
Halie, M. Ruud;
Vellenga, Edo

Publication type:

Article

Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation.

Published in:

British Journal of Haematology, 1987, v. 65, n. 2, p. 137, doi. 10.1111/j.1365-2141.1984.00521.x-i1

By:

Vellenga, Edo;
Sizoo, Willemijn;
Hagenbeek, Anton;
Löwenberg, Bob

Publication type:

Article

Diagnostic Performance and Prognostic Value of Extravascular Retention of 123I-Labeled Serum Amyloid P Component in Systemic Amyloidosis.

Published in:

Journal of Nuclear Medicine, 2007, v. 48, n. 6, p. 865, doi. 10.2967/jnumed.106.039313

By:

Hazenberg, Bouke P. C.;
van Rijswijk, Martin H.;
Lub-de Hooge, Marjolijn N.;
Vellenga, Edo;
Haagsma, Elizabeth B.;
Posthumus, Marcel D.;
Jager, Pieter L.

Publication type:

Article

18F-FLT PET in Hematologic Disorders: A Novel Technique to Analyze the Bone Marrow Compartment.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1592

By:

Agool, Ali;
Schot, Bart W.;
Jager, Pieter L.;
Vellenga, Edo

Publication type:

Article

Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels.

Published in:

Molecular & Cellular Biology, 2008, v. 28, n. 21, p. 6668, doi. 10.1128/MCB.01025-08

By:

Wierenga, Albertus T. J.;
Vellenga, Edo;
Schuringa, Jan Jacob

Publication type:

Article

A real-life cohort study of immunoglobulin light-chain (AL) amyloidosis patients ineligible for autologous stem cell transplantation due to severe cardiac involvement or advanced disease.

Published in:

Amyloid, 2020, v. 27, n. 2, p. 119, doi. 10.1080/13506129.2020.1714581

By:

Brunger, Anne F.;
Nienhuis, Hans L. A.;
Bijzet, Johan;
Roeloffzen, Wilfried W. H.;
Vellenga, Edo;
Hazenberg, Bouke P. C.

Publication type:

Article

Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016.

Published in:

Amyloid, 2018, v. 25, n. 4, p. 227, doi. 10.1080/13506129.2018.1536043

By:

Rutten, Karlijn H. G.;
Raymakers, Reinier A. P.;
Hazenberg, Bouke P. C.;
Nienhuis, Hans L. A.;
Vellenga, Edo;
Minnema, Monique C.

Publication type:

Article

AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation.

Published in:

Amyloid, 2002, v. 9, n. 3, p. 165, doi. 10.3109/13506120209114818

By:

van Gameren, Ingrid I.;
Hazenberg, Bouke P.C.;
Jager, Piet L.;
Smit, Jan W.;
Vellenga, Edo

Publication type:

Article

Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 2, p. 332, doi. 10.1007/s00259-016-3576-1

By:

Waal, Esther;
Glaudemans, Andor;
Schröder, Carolien;
Vellenga, Edo;
Slart, Riemer

Publication type:

Article

Radionuclide imaging of bone marrow disorders.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 1, p. 166, doi. 10.1007/s00259-010-1531-0

By:

Agool, Ali;
Glaudemans, Andor;
Boersma, Hendrikus;
Dierckx, Rudi;
Vellenga, Edo;
Slart, Riemer

Publication type:

Article

Extramedullary haematopoiesis imaging with 18F-FLT PET.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 8, p. 1620, doi. 10.1007/s00259-010-1486-1

By:

Agool, Ali;
Dierckx, Rudi A. J. O.;
de Wolf, Joost T. M.;
Vellenga, Edo;
Slart, Riemer H. J. A.

Publication type:

Article

Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 1, p. 124, doi. 10.1007/s00259-009-1199-5

By:

Agool, Ali;
Slart, Riemer;
Dierckx, Rudi;
Kluin, Philip;
Visser, Lydia;
Jager, Pieter;
Vellenga, Edo

Publication type:

Article

MEN2A-RET-induced cellular transformation by activation of STAT3.

Published in:

Oncogene, 2001, v. 20, n. 38, p. 5350, doi. 10.1038/sj.onc.1204715

By:

Schuringa, Jan Jacob;
Wojtachnio, Katarzyna;
Hagens, Werner;
Vellenga, Edo;
Buys, Charles HCM;
Hofstra, Robert;
Kruijer, Wiebe

Publication type:

Article

Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?

Published in:

Human Molecular Genetics, 2006, v. 15, n. 2, p. r210, doi. 10.1093/hmg/ddl175

By:

Rizo, Aleksandra;
Vellenga, Edo;
de Haan, Gerald;
Schuringa, Jan Jacob

Publication type:

Article

Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?

Published in:

Human Molecular Genetics, 2006, v. 15, n. suppl_2, p. R210, doi. 10.1093/hmg/ddl175

By:

Rizo, Aleksandra;
Vellenga, Edo;
de Haan, Gerald;
Schuringa, Jan Jacob

Publication type:

Article

All- trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.

Published in:

Annals of Hematology, 2015, v. 94, n. 8, p. 1347, doi. 10.1007/s00277-015-2393-0

By:

Sanz, Miguel;
Montesinos, Pau;
Kim, Haesook;
Ruiz-Argüelles, Guillermo;
Undurraga, María;
Uriarte, María;
Martínez, Lem;
Jacomo, Rafael;
Gutiérrez-Aguirre, Homero;
Melo, Raul;
Bittencourt, Rosane;
Pasquini, Ricardo;
Pagnano, Katia;
Fagundes, Evandro;
Vellenga, Edo;
Holowiecka, Alexandra;
González-Huerta, Ana;
Fernández, Pascual;
Serna, Javier;
Brunet, Salut

Publication type:

Article

Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases.

Published in:

2010

By:

Han, Lina;
Schuringa, Jan Jacob;
Mulder, André;
Vellenga, Edo;
Mulder, André

Publication type:

journal article

Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells.

Published in:

Annals of Hematology, 2009, v. 88, n. 6, p. 573, doi. 10.1007/s00277-008-0633-2

By:

de Jonge-Peeters, Susan D. P. W. M.;
van der Weide, Karen;
Kuipers, Folkert;
Sluiter, Wim J.;
de Vries, Elisabeth G. E.;
Vellenga, Edo

Publication type:

Article

Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura.

Published in:

Annals of Hematology, 2008, v. 87, n. 12, p. 975, doi. 10.1007/s00277-008-0537-1

By:

Houwerzijl, Ewout J.;
Louwes, Henk;
Sluiter, Wim J.;
Smit, Jan W.;
Vellenga, Edo;
de Wolf, Joost Th. M.

Publication type:

Article

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.

Published in:

2007

By:

van den Heuvel-Eibrink, Marry M.;
van der Holt, Bronno;
Burnett, Alan K.;
Knauf, Wolfgang U.;
Fey, Martin F.;
Verhoef, Gregor E. G.;
Vellenga, Edo;
Ossenkoppele, Gert J.;
Löwenberg, Bob;
Sonneveld, Pieter;
Löwenberg, Bob

Publication type:

journal article

Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study.

Published in:

Annals of Hematology, 2005, v. 84, n. 5, p. 311, doi. 10.1007/s00277-004-0981-5

By:

Hovenga, Sjoerd;
Daenen, Simon M. G. J.;
de Wolf, Joost T. M.;
van Imhoff, Gustaaf W.;
Kluin-Nelemans, Hanneke C.;
Sluiter, Wim J.;
Vellenga, Edo

Publication type:

Article

Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic Leukemia*.

Published in:

Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 3, p. 220, doi. 10.1016/j.clpt.2004.05.007

By:

Plasschaert, Sabine L. A.;
Groninger, Ellis;
Boezen, Marike;
Kema, Ido;
de Vries, Elisabeth G. E.;
Uges, Donald;
Veerman, Anjo J. P.;
Kamps, Willem A.;
Vellenga, Edo;
de Graaf, Siebold S.;
de Bont, Eveline S. J. M.

Publication type:

Article

Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.

Published in:

Genes, Chromosomes & Cancer, 2017, v. 56, n. 7, p. 524, doi. 10.1002/gcc.22455

By:

Stevens‐Kroef, Marian J.;
Olde Weghuis, Daniel;
ElIdrissi‐Zaynoun, Najat;
van der Reijden, Bert;
Cremers, Eline M. P.;
Alhan, Canan;
Westers, Theresia M.;
Visser‐Wisselaar, Heleen A.;
Chitu, Dana A.;
Cunha, Sonia M.;
Vellenga, Edo;
Klein, Saskia K.;
Wijermans, Pierre;
de Greef, Georgine E.;
Schaafsma, M. Ron;
Muus, Petra;
Ossenkoppele, Gert J.;
van de Loosdrecht, Arjan A.;
Jansen, Joop H.

Publication type:

Article

Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.

Published in:

Intensive Care Medicine, 2003, v. 29, n. 12, p. 2157, doi. 10.1007/s00134-003-2026-2

By:

Nijhuis, Claudi S. M. Oude;
Vellenga, Edo;
Daenen, Simon M. G. J.;
van der Graaf, Winette T. A.;
Gietema, Jourik A.;
Groen, Harry J. M.;
Kamps, Willem A.;
de Bont, Eveline S. J. M.

Publication type:

Article

Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co‐occurring FANCC and CHEK2 mutations.

Published in:

British Journal of Haematology, 2019, v. 184, n. 6, p. 1071, doi. 10.1111/bjh.15265

By:

Berger, Gerbrig;
Berg, Eva;
Smetsers, Stephanie;
Leegte, Beike K.;
Sijmons, Rolf H.;
Abbott, Kristin M.;
Mulder, André B.;
Vellenga, Edo

Publication type:

Article

Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2017, v. 178, n. 5, p. 810, doi. 10.1111/bjh.14166

By:

Helm, Lieke H.;
Berger, Gerbrig;
Diepstra, Arjan;
Huls, Gerwin;
Vellenga, Edo

Publication type:

Article